Trial of canakinumab, an IL-1β receptor antagonist, in...

Neurology: Neuroimmunology & Neuroinflammation 2019 / 07 Vol. 6; Iss. 4

Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis

Kosmidis, Michalis L., Pikazis, Dimitris, Vlachoyiannopoulos, Panayotis, Tzioufas, Athanasios G., Dalakas, Marinos C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Neurology - Neuroimmunology Neuroinflammation
DOI:
10.1212/NXI.0000000000000581
Date:
July, 2019
File:
PDF, 311 KB
english, 2019
Conversion to is in progress
Conversion to is failed